Andrew Mok
Stock Analyst at Barclays
(3.34)
# 921
Out of 5,182 analysts
285
Total ratings
51.53%
Success rate
1.53%
Average return
Main Sectors:
Stocks Rated by Andrew Mok
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UHS Universal Health Services | Maintains: Overweight | $268 → $238 | $176.98 | +34.48% | 28 | Apr 28, 2026 | |
| HCA HCA Healthcare | Maintains: Overweight | $551 → $496 | $449.30 | +10.39% | 19 | Apr 27, 2026 | |
| ELV Elevance Health | Maintains: Overweight | $393 → $408 | $359.36 | +13.54% | 17 | Apr 24, 2026 | |
| MOH Molina Healthcare | Maintains: Underweight | $133 → $161 | $180.28 | -10.69% | 13 | Apr 24, 2026 | |
| CYH Community Health Systems | Maintains: Equal-Weight | $3.5 → $3 | $2.83 | +6.01% | 8 | Apr 23, 2026 | |
| UNH UnitedHealth Group | Maintains: Overweight | $327 → $373 | $356.66 | +4.58% | 16 | Apr 22, 2026 | |
| RDNT RadNet | Maintains: Overweight | $86 → $70 | $58.00 | +20.69% | 10 | Apr 21, 2026 | |
| LMRI Lumexa Imaging Holdings | Maintains: Overweight | $23 → $15 | $9.60 | +56.25% | 1 | Apr 14, 2026 | |
| PRVA Privia Health Group | Maintains: Equal-Weight | $23 → $25 | $24.25 | +3.09% | 11 | Mar 25, 2026 | |
| AVAH Aveanna Healthcare Holdings | Maintains: Overweight | $11 → $9.5 | $6.77 | +40.32% | 4 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $112 → $102 | - | - | 6 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $14 | - | - | 6 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $14 → $20 | $28.18 | -29.03% | 21 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $25 → $13 | - | - | 6 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $245 → $176 | $227.03 | -22.48% | 16 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $240 → $257 | - | - | 17 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $150 → $153 | - | - | 19 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $305 → $303 | $286.63 | +5.71% | 11 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $186 → $190 | - | - | 15 | Feb 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $18 | $13.85 | +29.96% | 3 | Feb 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $13 → $18 | $17.16 | +4.90% | 4 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $44 → $54 | $44.41 | +21.59% | 13 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 → $93 | $79.64 | +16.78% | 12 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $36 → $26 | $34.27 | -24.13% | 2 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $13 → $18 | $21.22 | -15.15% | 6 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $12 | $13.76 | -12.79% | 1 | Dec 8, 2022 |
Universal Health Services
Apr 28, 2026
Maintains: Overweight
Price Target: $268 → $238
Current: $176.98
Upside: +34.48%
HCA Healthcare
Apr 27, 2026
Maintains: Overweight
Price Target: $551 → $496
Current: $449.30
Upside: +10.39%
Elevance Health
Apr 24, 2026
Maintains: Overweight
Price Target: $393 → $408
Current: $359.36
Upside: +13.54%
Molina Healthcare
Apr 24, 2026
Maintains: Underweight
Price Target: $133 → $161
Current: $180.28
Upside: -10.69%
Community Health Systems
Apr 23, 2026
Maintains: Equal-Weight
Price Target: $3.5 → $3
Current: $2.83
Upside: +6.01%
UnitedHealth Group
Apr 22, 2026
Maintains: Overweight
Price Target: $327 → $373
Current: $356.66
Upside: +4.58%
RadNet
Apr 21, 2026
Maintains: Overweight
Price Target: $86 → $70
Current: $58.00
Upside: +20.69%
Lumexa Imaging Holdings
Apr 14, 2026
Maintains: Overweight
Price Target: $23 → $15
Current: $9.60
Upside: +56.25%
Privia Health Group
Mar 25, 2026
Maintains: Equal-Weight
Price Target: $23 → $25
Current: $24.25
Upside: +3.09%
Aveanna Healthcare Holdings
Mar 25, 2026
Maintains: Overweight
Price Target: $11 → $9.5
Current: $6.77
Upside: +40.32%
Mar 25, 2026
Maintains: Underweight
Price Target: $112 → $102
Current: -
Upside: -
Mar 3, 2026
Maintains: Equal-Weight
Price Target: $18 → $14
Current: -
Upside: -
Mar 3, 2026
Maintains: Equal-Weight
Price Target: $14 → $20
Current: $28.18
Upside: -29.03%
Feb 27, 2026
Maintains: Underweight
Price Target: $25 → $13
Current: -
Upside: -
Feb 25, 2026
Maintains: Equal-Weight
Price Target: $245 → $176
Current: $227.03
Upside: -22.48%
Feb 13, 2026
Maintains: Overweight
Price Target: $240 → $257
Current: -
Upside: -
Feb 6, 2026
Maintains: Overweight
Price Target: $150 → $153
Current: -
Upside: -
Feb 6, 2026
Maintains: Overweight
Price Target: $305 → $303
Current: $286.63
Upside: +5.71%
Feb 4, 2026
Maintains: Buy
Price Target: $186 → $190
Current: -
Upside: -
Feb 3, 2026
Maintains: Overweight
Price Target: $15 → $18
Current: $13.85
Upside: +29.96%
Jan 5, 2026
Upgrades: Equal-Weight
Price Target: $13 → $18
Current: $17.16
Upside: +4.90%
Jan 5, 2026
Upgrades: Overweight
Price Target: $44 → $54
Current: $44.41
Upside: +21.59%
Dec 10, 2025
Maintains: Overweight
Price Target: $87 → $93
Current: $79.64
Upside: +16.78%
Nov 24, 2025
Maintains: Equal-Weight
Price Target: $36 → $26
Current: $34.27
Upside: -24.13%
Nov 3, 2025
Maintains: Equal-Weight
Price Target: $13 → $18
Current: $21.22
Upside: -15.15%
Dec 8, 2022
Initiates: Sell
Price Target: $12
Current: $13.76
Upside: -12.79%